BTS has set new concert revenue records at four major U.S. stadiums during the North American leg of its Arirang world tour, adding another measurable milestone to the group’s 2026 return to large-scale touring. Current reporting identifies record-setting grosses at Allegiant Stadium, Gillette Stadium, M&T Bank Stadium and Raymond James Stadium, showing that the tour’s commercial impact is being felt venue by venue rather than only through an overall tour total.
The figures are substantial even by stadium-tour standards. Current tour data put the gross from the Tampa run at Raymond James Stadium at about $40.7 million, while reporting on the four-record milestone places Allegiant Stadium at roughly $49.5 million. Those amounts come from multi-show stadium stops, where high attendance and premium ticket pricing can push a single city engagement into the revenue range normally associated with an entire arena tour leg.
From tour totals to venue records
The new records are distinct from the monthly revenue milestone KORInform covered in late August. That earlier story showed the scale of BTS’s touring business across a broader period. The latest development demonstrates how that demand translates into individual venue economics, with the group surpassing previous concert gross benchmarks at multiple U.S. stadiums during the same tour.
For the K-pop industry, the significance lies in repeatability. Stadium sellouts have become part of the global success story for top Korean acts, but venue revenue records add a harder commercial measure to audience size alone. The remaining North American and international dates will show whether BTS continues to reset local benchmarks as the Arirang tour moves through more markets.
